United States · 
Who invested in ENSEM Therapeutics?
ENSEM Therapeutics's investors include GGV Capital, Legend Star and Pavilion Capital.
United States · Series A startup
Who invested in ENSEM Therapeutics
Funding summaryUpdated 26 Oct 2026
$10Mraised across 1 round since 2023, from 1 source
- Latest round
- Series A, $10MOct 2023
- Investors
- 3
The rounds
- Oct 2023
Founders and team
From ENSEM Therapeutics's own website: 1 on the team.
- Richard MitranoVice President of Finance and Accounting
AdvisersDuncan Higgons
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about ENSEM Therapeutics
How much has ENSEM Therapeutics raised?
ENSEM Therapeutics has raised $10M across 1 round since 2023.
When did ENSEM Therapeutics last raise?
ENSEM Therapeutics's most recent round was a Series A of $10M in Oct 2023.
What was ENSEM Therapeutics's biggest round?
Its most recent round, $10M in Oct 2023, is also its largest on record.
Who backed ENSEM Therapeutics first?
ENSEM Therapeutics's first round on record, in Oct 2023, was backed by GGV Capital, Legend Star and Pavilion Capital.
What stage is ENSEM Therapeutics at?
ENSEM Therapeutics's latest named round is a Series A, in Oct 2023.
Where is ENSEM Therapeutics based?
ENSEM Therapeutics is based in the United States.
Companies like ENSEM Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.